NEW YORK (GenomeWeb) – In Nature Genetics, an international team led by investigators at St. Jude Children's Research Hospital described variants in the ACYP2 gene that appear to notch up the risk of hearing loss in children treated with the anticancer drug cisplatin.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.